Patrick O’Donnell

Assessment of <i>EGFR</i> Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)

Chris Karlovich, Jonathan W. Goldman, Jong‐Mu Sun et al. · Clinical Cancer Research · 2016 · 178 citations · Full text

A Phase 1B Study of Pembrolizumab (Pembro; Mk-3475) in Patients (Pts) with Advanced Urothelial Tract Cancer

Elizabeth R. Plimack, Shilpa Gupta, Joaquim Bellmunt et al. · Annals of Oncology · 2014 · 51 citations · Full text

Phase 1B, Urology, Genitourinary Cancer +4

Analytic performance studies and clinical reproducibility of a real-time PCRassay for the detection of epidermal growth factor receptor gene mutations informalin-fixed paraffin-embedded tissue specimens of non-small cell lungcancer

Patrick O’Donnell, Jane Ferguson, Johnny Shyu et al. · BMC Cancer · 2013 · 48 citations · Full text

21LBA Atezolizumab in patients (pts) with locally-advanced or metastatic urothelial carcinoma (mUC): Results from a pivotal multicenter phase II study (IMvigor 210)

J. Rosenberg, Daniel P. Petrylak, Oyewale O. Abidoye et al. · European Journal of Cancer · 2015 · 14 citations

Urology, Metastatic Urothelial Carcinoma, Genitourinary Cancer +6

In Vivo Purging With Rituximab During Stem Cell Transplantation for Indolent Lymphoma

Patrick O’Donnell · 2000 · 11 citations

Cell Therapy, Autologous Graft, Immunology +16